Myelodysplastic Syndromes News and Research

RSS
New mechanism of differentiation may offer novel therapeutic approaches to blood malignancies, solid tumors

New mechanism of differentiation may offer novel therapeutic approaches to blood malignancies, solid tumors

McMaster University researchers take a giant leap in detecting early stages of leukemia

McMaster University researchers take a giant leap in detecting early stages of leukemia

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Drug combination produces long-term responses in patients with mantle cell lymphoma

Drug combination produces long-term responses in patients with mantle cell lymphoma

UCSD researchers suggest that cancer-related mutations common in patients with low blood counts

UCSD researchers suggest that cancer-related mutations common in patients with low blood counts

Self-reported fatigue predicts myelodysplastic syndromes survival

Self-reported fatigue predicts myelodysplastic syndromes survival

Researchers identify druggable target to potentially root out colon cancer, end relapse

Researchers identify druggable target to potentially root out colon cancer, end relapse

Study of genetic mutations could lead to optimized treatment plans for aplastic anemia patients

Study of genetic mutations could lead to optimized treatment plans for aplastic anemia patients

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

MD Anderson researchers discover link between telomere degeneration and MDS

MD Anderson researchers discover link between telomere degeneration and MDS

Aptose begins APTO-253 clinical study in patients with relapsed or refractory hematologic malignancies

Aptose begins APTO-253 clinical study in patients with relapsed or refractory hematologic malignancies

Novel targeted therapies and treatment combinations for leukemia

Novel targeted therapies and treatment combinations for leukemia

Emerging strategies to boost healthy RBCs may reduce burden of anemia linked to blood disorders

Emerging strategies to boost healthy RBCs may reduce burden of anemia linked to blood disorders

Moffitt announces development of innovative investigational biologic agent for MDS

Moffitt announces development of innovative investigational biologic agent for MDS

Scientists use Rapid Heme Panel test to identify right treatment for leukemia, other blood cancers

Scientists use Rapid Heme Panel test to identify right treatment for leukemia, other blood cancers

M2Gen, Moffitt to serve as Central Laboratory and Biorepository for The National MDS Study

M2Gen, Moffitt to serve as Central Laboratory and Biorepository for The National MDS Study

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc Panel

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc Panel

CleveXel Pharma receives license for two new oncology patents

CleveXel Pharma receives license for two new oncology patents

Aptose joins Beat AML research collaboration

Aptose joins Beat AML research collaboration

InnoPharma receives FDA approval for generic DACOGEN

InnoPharma receives FDA approval for generic DACOGEN